Article

biopharm_december_2010_bpa_statement

BioPharm 2010 December statement

To view a PDF of this article from the BioPharm International archives, click this link

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!
Related Videos
Related Content
Creative image of embryonic stem cells, cellular therapy. 3d illustration | Image Credit: © pinkeyes - © pinkeyes - stock.adobe.com
September 16th 2025

Limula’s LimONE System Targets Consistency in Stem Cell Transplants

Feliza Mirasol
The Future of Cleanroom Construction: How Hybrid Solutions are Changing the Game
September 16th 2025

The Future of Cleanroom Construction: How Hybrid Solutions are Changing the Game

G-CON
Hand shaking which print screen on wooden cube block in front of human icon for business deal and agreement concept | Image Credit: © Dilok – © Dilok - stock.adobe.com
September 16th 2025

Monte Rosa and Novartis Partner to Target Undruggable Immunology Pathways with Degraders

Feliza Mirasol
Mastering Antibody-Drug Conjugates
September 16th 2025

Mastering Antibody-Drug Conjugates

BIOVECTRA
Drug manufacturing process. Conveyor with medical ampoules line at a modern pharmaceutical plant. Pharmacology production, medicine industry from laboratory 2 factory, pharmacy. Healthcare, pharma 3D | Image Credit: © Corona Borealis - © Corona Borealis - stock.adobe.com
September 16th 2025

PDA 2025: How Strategic CAPA Builds Anti-Fragile Manufacturing Compliance

Feliza Mirasol
Digital information travels through fiber optic cables through the network and data servers behind glass panels in the server room of the data center. High speed digital lines 3d illustration | Image Credit: © flashmovie - © flashmovie - stock.adobe.com
September 16th 2025

PDA 2025: How Automation Assures Product Quality for Next-Gen Biopharma

Feliza Mirasol
© 2025 MJH Life Sciences

All rights reserved.